1. Home
  2. MURA vs LITB Comparison

MURA vs LITB Comparison

Compare MURA & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • LITB
  • Stock Information
  • Founded
  • MURA 2013
  • LITB 2007
  • Country
  • MURA Ireland
  • LITB Singapore
  • Employees
  • MURA N/A
  • LITB N/A
  • Industry
  • MURA
  • LITB Catalog/Specialty Distribution
  • Sector
  • MURA
  • LITB Consumer Discretionary
  • Exchange
  • MURA Nasdaq
  • LITB Nasdaq
  • Market Cap
  • MURA 36.0M
  • LITB 36.4M
  • IPO Year
  • MURA N/A
  • LITB N/A
  • Fundamental
  • Price
  • MURA $2.09
  • LITB $3.88
  • Analyst Decision
  • MURA Buy
  • LITB
  • Analyst Count
  • MURA 2
  • LITB 0
  • Target Price
  • MURA $6.00
  • LITB N/A
  • AVG Volume (30 Days)
  • MURA 103.1K
  • LITB 32.6K
  • Earning Date
  • MURA 11-04-2025
  • LITB 12-09-2025
  • Dividend Yield
  • MURA N/A
  • LITB N/A
  • EPS Growth
  • MURA N/A
  • LITB N/A
  • EPS
  • MURA N/A
  • LITB 0.12
  • Revenue
  • MURA N/A
  • LITB $220,656,000.00
  • Revenue This Year
  • MURA N/A
  • LITB N/A
  • Revenue Next Year
  • MURA N/A
  • LITB N/A
  • P/E Ratio
  • MURA N/A
  • LITB $31.68
  • Revenue Growth
  • MURA N/A
  • LITB N/A
  • 52 Week Low
  • MURA $0.95
  • LITB $0.91
  • 52 Week High
  • MURA $4.74
  • LITB $4.17
  • Technical
  • Relative Strength Index (RSI)
  • MURA 52.55
  • LITB 72.61
  • Support Level
  • MURA $2.06
  • LITB $2.54
  • Resistance Level
  • MURA $2.10
  • LITB $4.17
  • Average True Range (ATR)
  • MURA 0.01
  • LITB 0.43
  • MACD
  • MURA 0.00
  • LITB 0.12
  • Stochastic Oscillator
  • MURA 66.67
  • LITB 78.36

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: